Inventor
ALAN R. MEYER
Inventor
US
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes50%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations50%
PatentTitleYear
12,576,066Methods and compositions for treatment of mydriasis202612,576,067Methods and compositions for treatment of mydriasis202612,201,616Methods and compositions for treatment of mydriasis202512,201,615Methods and compositions for treatment of mydriasis202512,161,629Methods and compositions for treatment of glaucoma and related conditions202412,016,841Methods and compositions for treatment of presbyopia, mydriasis, and other ocular disorders202411,844,858Aqueous ophthalmic solutions of phentolamine and medical uses thereof202311,400,077Methods and compositions for treatment of presbyopia, mydriasis, and other ocular disorders2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2024Patents assigned to OCUPHIRE PHARMA INC (3)· patent assignee history
2022–2026Based in US· patent location history
2024–2026Patents assigned to OPUS GENETICS INC (5)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| OPUS GENETICS INC | 5 | 2024–2026 |
| OCUPHIRE PHARMA INC | 3 | 2022–2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 8 | 2022–2026 |